{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&legislature.prefLabel=House+of+Lords&answer.isMinisterialCorrection=false", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptId=17&legislature.prefLabel=House+of+Lords&answer.isMinisterialCorrection=false", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&legislature.prefLabel=House+of+Lords&answer.isMinisterialCorrection=false&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&answeringDeptId=17&legislature.prefLabel=House+of+Lords&answer.isMinisterialCorrection=false", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&legislature.prefLabel=House+of+Lords&answer.isMinisterialCorrection=false", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptId=17&legislature.prefLabel=House+of+Lords&answer.isMinisterialCorrection=false", "items" : [{"_about" : "http://data.parliament.uk/resources/1733458", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1733458/answer", "answerText" : {"_value" : "

In addition to the ongoing efforts to control Mpox clade IIb in the United Kingdom, there is widespread planning underway across the Government, including work by the Department, the UK Health Security Agency, and the National Health Service, to prepare for any potential cases of the high consequence infectious disease clades Ia or Ib of Mpox in the UK, and to help prevent onward transmission should any cases be imported.<\/p>

An established clinical countermeasures programme is a core component of our pandemic preparedness and response capability. These clinical countermeasures include personal protective equipment and hygiene consumables, vaccines, and therapeutics, such as antivirals. The programme, including the balance of antivirals stockpiled, is informed by scientific and clinical assessment of the evidence base and is kept under review, building on lessons learned from previous outbreaks and emerging evidence on efficacy from ongoing clinical trials in epidemic hotspots.<\/p>

The Department has noted the recent PALM007 study. The NHS in England has a duty to make available to patients in England any treatment or product recommended as clinically and cost effective by the National Institute for Health and Care Excellence.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/347", "label" : {"_value" : "Biography information for Baroness Merron"} } , "answeringMemberPrinted" : {"_value" : "Baroness Merron"} , "dateOfAnswer" : {"_value" : "2024-10-18", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-10-18T10:57:33.573Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-10-10", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mpox: Vaccination"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government whether, since the PALM007 study has shown the antiviral ingredient tecovirimat does not always reduce the duration of mpox lesions, a mixed stockpile of antiviral agents for mpox is being considered.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4340", "label" : {"_value" : "Biography information for Lord Cashman"} } , "tablingMemberPrinted" : [{"_value" : "Lord Cashman"} ], "uin" : "HL1489"} , {"_about" : "http://data.parliament.uk/resources/1733459", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1733459/answer", "answerText" : {"_value" : "

The Generation Study screens for over 200 conditions which were selected on a set of four principles. The expression, or penetrance, of 22q11.2 deletion syndrome is incomplete, meaning that some people with the syndrome may have no features of the condition. For this and many other conditions, including other microdeletion and microduplication syndromes, Genomics England has taken a conservative approach when applying the four principles, selecting only those conditions where penetrance is high and where treatment must be initiated very early in essentially all cases. Genomics England will review and add conditions during the course of the programme, and will publicise information about any review.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/347", "label" : {"_value" : "Biography information for Baroness Merron"} } , "answeringMemberPrinted" : {"_value" : "Baroness Merron"} , "dateOfAnswer" : {"_value" : "2024-10-18", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-10-18T10:59:16.713Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-10-10", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Genomics: Babies"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government why the Genomics England and NHS England \u2018Generation Study\u2019, offering 100,000 newborns whole genome sequencing after birth to diagnose and support a number of genetic conditions, does not include 22q11.2 deletion syndrome which meets the four requisite principles for inclusion.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4321", "label" : {"_value" : "Biography information for Lord Farmer"} } , "tablingMemberPrinted" : [{"_value" : "Lord Farmer"} ], "uin" : "HL1490"} , {"_about" : "http://data.parliament.uk/resources/1733076", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1733076/answer", "answerText" : {"_value" : "

As part of ongoing considerations, NHS England intends to launch a pilot in the coming months extending the Electronic Prescription Service to specific Detained Estate health services in England. Amendments to the National Health Service (Charges for Drugs and Appliances) Regulations 2015 will be made in the autumn, subject to parliamentary time.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/347", "label" : {"_value" : "Biography information for Baroness Merron"} } , "answeringMemberPrinted" : {"_value" : "Baroness Merron"} , "dateOfAnswer" : {"_value" : "2024-10-18", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-10-18T10:55:59.057Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-10-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Prescriptions: Prisons"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 8 October (HL957), when they expect considerations on extending the Electronic Prescription Service to conclude, and a decision to be taken.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/452", "label" : {"_value" : "Biography information for Lord Bradley"} } , "tablingMemberPrinted" : [{"_value" : "Lord Bradley"} ], "uin" : "HL1441"} , {"_about" : "http://data.parliament.uk/resources/1733098", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1733098/answer", "answerText" : {"_value" : "

General practices (GPs) and primary care have been receiving a smaller proportion of National Health Service resources, and we\u2019re committed to reversing that and shifting the focus of care out of hospitals and into the community. Additionally, we acknowledge the pressing challenge of ensuring that rural areas have the resources to continue serving their patients.<\/p>

We have already invested £82 million to recruit 1,000 newly qualified GPs to combat this, and our 10-Year Health Plan will outline steps to shift care from hospitals back to the community and to a Neighbourhood Health Service, which will bring together vital health and care services, ensuring healthcare is closer to home. We will also train more doctors to increase capacity and take the pressure of people currently working in the system.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/347", "label" : {"_value" : "Biography information for Baroness Merron"} } , "answeringMemberPrinted" : {"_value" : "Baroness Merron"} , "dateOfAnswer" : {"_value" : "2024-10-18", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-10-18T10:58:39.823Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-10-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Health Services: Rural Areas and Urban Areas"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government whether their 10-year plan for the NHS will address the distribution of resources between (1) primary and secondary care and (2) urban and rural areas.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/384", "label" : {"_value" : "Biography information for Baroness McIntosh of Pickering"} } , "tablingMemberPrinted" : [{"_value" : "Baroness McIntosh of Pickering"} ], "uin" : "HL1463"} , {"_about" : "http://data.parliament.uk/resources/1733099", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1733099/answer", "answerText" : {"_value" : "

An out of area placement (OAP) for acute mental health in-patient care happens when a person with assessed acute mental health needs, who requires adult mental health acute inpatient care, is admitted to a unit that does not form part of the usual local network of services.<\/p>

By this, we mean an inpatient unit that does not usually admit people living in the catchment of the person\u2019s local community mental health service, and where the person cannot be visited regularly by their care co-ordinator to ensure continuity of care and effective discharge planning.<\/p>

Sending Providers are to determine if a placement is classed as an OAP. The definition necessarily allows providers to apply knowledge of local catchment arrangements and the patient\u2019s circumstances in taking a decision if a placement is an OAP. OAPs can occur within one NHS Provider, in other NHS Providers, or in Independent Sector Providers.<\/p>

Based on this definition of an adult acute mental health OAP, it is the decision and responsibility of the Sending Provider to submit data identifying the OAP based on the provider\u2019s knowledge of local catchment arrangements and the person\u2019s circumstances. The definition necessarily allows providers the flexibility to make this decision<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/347", "label" : {"_value" : "Biography information for Baroness Merron"} } , "answeringMemberPrinted" : {"_value" : "Baroness Merron"} , "dateOfAnswer" : {"_value" : "2024-10-15", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-10-15T14:58:46.613Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-10-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mental Health Services"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 11 September (HL813), whether their definition of \"out of areas placement\" includes admission to an appropriate independent sector mental health inpatient facility, which is in the patient\u2019s local area and where his or her care co-ordinator can visit regularly.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3798", "label" : {"_value" : "Biography information for Lord Patel of Bradford"} } , "tablingMemberPrinted" : [{"_value" : "Lord Patel of Bradford"} ], "uin" : "HL1464"} , {"_about" : "http://data.parliament.uk/resources/1733114", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1733114/answer", "answerText" : {"_value" : "

The Government is committed to improving out-of-hospital cardiac arrests. As part of this commitment, we want to increase access to Automated External Defibrillators (AEDs) in public spaces and reduce inequalities in access to these life saving devices. We have made a further £500,000 available from August 2024 to fulfil existing applications to the Department\u2019s Community AED Fund. The criteria specified for the original grant continues to apply and will go to applications for AEDs in areas where there is the greatest need, including in areas of high footfall, hot spots for cardiac arrest, and areas that already have low access to AEDs.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/347", "label" : {"_value" : "Biography information for Baroness Merron"} } , "answeringMemberPrinted" : {"_value" : "Baroness Merron"} , "dateOfAnswer" : {"_value" : "2024-10-16", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-10-16T16:47:10.37Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-10-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Heart Diseases"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what plans they have to improve survival rates for those who have out-of-hospital cardiac arrests.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4308", "label" : {"_value" : "Biography information for The Lord Bishop of St Albans"} } , "tablingMemberPrinted" : [{"_value" : "The Lord Bishop of St Albans"} ], "uin" : "HL1479"} , {"_about" : "http://data.parliament.uk/resources/1732625", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1732625/answer", "answerText" : {"_value" : "

The Government is determined to shift more healthcare out of hospitals and into the community, to ensure that patients and their families receive personalised care in the most appropriate setting and palliative and end of life care, including hospices, will have a big role to play in that shift.<\/p>

Palliative care services are included in the list of services an integrated care board (ICB) must commission. This promotes a more consistent national approach and supports commissioners in prioritising palliative and end of life care. To support ICBs in this duty, NHS England has published statutory guidance and service specifications.<\/p>

Whilst the majority of palliative and end of life care is provided by National Health Service staff and services, we recognise the vital part that voluntary sector organisations, including hospices, also play in providing support to people at end of life and their loved ones.<\/p>

Most hospices are charitable, independent organisations which receive some statutory funding for providing NHS services. The amount of funding charitable hospices receive varies by ICB area, and will, in part, be dependent on the breadth of a range of palliative and end of life care provision within their ICB footprint.<\/p>

The Department will continue to proactively engage with our stakeholders, including the voluntary sector and independent hospices, on an ongoing basis, in order to understand the issues they face.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/347", "label" : {"_value" : "Biography information for Baroness Merron"} } , "answeringMemberPrinted" : {"_value" : "Baroness Merron"} , "dateOfAnswer" : {"_value" : "2024-10-15", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-10-15T15:35:54.2Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-10-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Hospices: Finance"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what plans they have to increase funding to hospices in England.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/452", "label" : {"_value" : "Biography information for Lord Bradley"} } , "tablingMemberPrinted" : [{"_value" : "Lord Bradley"} ], "uin" : "HL1372"} , {"_about" : "http://data.parliament.uk/resources/1731656", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1731656/answer", "answerText" : {"_value" : "

Both NHS England and integrated care boards (ICBs) are required to put in place access for any treatment that carries a positive recommendation from the Technology Appraisal programme, operated by the National Institute for Health and Care Excellence (NICE).<\/p>

Where treatments are approved by NICE through the Technology Appraisals programme, the National Health Service is required to fund and make them available within agreed timescales, which vary by technology. Implementation of any NICE approvals will be supported by the service readiness assessment and the development of additional capacity where necessary.<\/p>

During 2024/25, NHS England will continue to support all ICBs in integrating the planning and commissioning of suitable specialised services with their wider population-level commissioning responsibilities, in line with their individual timeline for delegation. Service Development Funding (SDF) is available to support Cancer Alliances to deliver the priorities set out in the 2024/25 NHS Operational Planning Guidance; £266 million in SDF is being provided to Cancer Alliances in 2024/25. Funding comprises two allocations: place-based, provided to all Alliances on a fair shares basis; and, targeted, provided to a selection of Alliances for agreed targeted projects. Cancer SDF is provided to Cancer Alliances via their lead ICBs to enable them to deliver on NHS-wide priorities for cancer, in line with their local delivery plans which are included in their funding agreement.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/347", "label" : {"_value" : "Biography information for Baroness Merron"} } , "answeringMemberPrinted" : {"_value" : "Baroness Merron"} , "dateOfAnswer" : {"_value" : "2024-10-11", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-10-11T13:26:54.117Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-10-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cancer: Medical Treatments"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what steps they are taking to secure funding for and expand access to minimally invasive cancer therapies approved by the National Institute for Health and Care Excellence across NHS Trusts.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3609", "label" : {"_value" : "Biography information for Baroness Finlay of Llandaff"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Finlay of Llandaff"} ], "uin" : "HL1205"} , {"_about" : "http://data.parliament.uk/resources/1731657", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1731657/answer", "answerText" : {"_value" : "

The adoption of new treatments, including increasing the number and availability of minimally invasive cancer treatments, into the National Health Service in England is generally the result of National Institute for Health and Care Excellence (NICE) guidance and commissioner decisions. Both NHS England and the integrated care boards (ICBs) are required to put in place access for any treatment that carries a positive recommendation from the Technology Appraisal programme, operated by the NICE.<\/p>

Where treatments are approved by the NICE through the Technology Appraisals programme, the NHS is required to fund and make them available within agreed timescales, which vary by technology. Implementation of any NICE approvals will be supported by the service readiness assessment and the development of additional capacity where necessary.<\/p>

During 2024/25, NHS England will continue to support all ICBs in integrating the planning and commissioning of suitable specialised services with their wider population-level commissioning responsibilities, in line with their individual timeline for delegation.<\/p>

We are committed to training the staff we need to get patients seen on time. The Government will make sure the NHS has the staff it needs to be there for all of us when we need it, including cancer patients.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/347", "label" : {"_value" : "Biography information for Baroness Merron"} } , "answeringMemberPrinted" : {"_value" : "Baroness Merron"} , "dateOfAnswer" : {"_value" : "2024-10-16", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-10-16T12:07:37.82Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-10-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cancer: Medical Treatments"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what steps they are taking to ensure that NHS Trusts have the necessary funding and trained staff to deliver minimally invasive cancer therapies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3609", "label" : {"_value" : "Biography information for Baroness Finlay of Llandaff"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Finlay of Llandaff"} ], "uin" : "HL1206"} , {"_about" : "http://data.parliament.uk/resources/1731687", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1731687/answer", "answerText" : {"_value" : "

The Government has set out plans to publish a ten-year plan to reform the National Health Service. The plan will be informed by Lord Darzi\u2019s report and will include further details on how we will improve cancer diagnosis, treatment, and outcomes. The 10-Year Cancer Plan commissioned in 2022 was not completed and a formal assessment has not been made.<\/p>

Lord Darzi\u2019s report has set out the scale of the challenges we face in fixing the NHS and the need to improve cancer waiting time performance and cancer survival. In particular, he highlighted the need to improve the number of patients starting their treatment within 62 days of referral and to increase the number of patients diagnosed at an earlier stage.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/347", "label" : {"_value" : "Biography information for Baroness Merron"} } , "answeringMemberPrinted" : {"_value" : "Baroness Merron"} , "dateOfAnswer" : {"_value" : "2024-10-11", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL1308"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-10-11T13:25:43.58Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-10-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cancer: Health Services"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what assessment they have made of the 10-Year Cancer Plan for England.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4130", "label" : {"_value" : "Biography information for Baroness Ritchie of Downpatrick"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Ritchie of Downpatrick"} ], "uin" : "HL1306"} ], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&answeringDeptId=17&legislature.prefLabel=House+of+Lords&answer.isMinisterialCorrection=false", "page" : 0, "startIndex" : 1, "totalResults" : 11401, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }